
Website Address:
http://www.circadian.com.au
Corporate Member:
Mr Robert Klupacs
CEO
Company Profile:
Circadian Technologies Limited is an Australian biotechnology company and an emerging leader in the field of angiogenesis-based treatments for cancer.
Focusing on a class of drug targets called Vascular Endothelial Growth Factors (VEGFs),
which play a critical role in regulating tumour blood supply, we seek to develop truly novel therapies to extend and improve the lives of cancer sufferers.